Titan Medical was officially delisted from the Nasdaq in March 2023 because its share price stayed below $1.00 for too long.
Most recent quotes for related tickers range from $0.28 to $0.40 (USD/CAD) as of late April 2026. should i buy titan medical stock
The company is now a "micro-cap" stock, valued at roughly $33 million to $40 million , which makes it extremely sensitive to small pieces of news. Summary Checklist: Should You Buy? Consideration Risk Tolerance Titan Medical was officially delisted from the Nasdaq
Deciding whether to buy stock in requires looking at a company that has undergone massive structural changes over the last few years. As of early 2026, the short answer is that the original "Titan Medical" (TMDI) essentially no longer exists as an independent surgical robotics company following a reverse take-over and a delisting from major exchanges . 1. The Core Business Has Shifted Summary Checklist: Should You Buy
Make sure you aren't confusing this with other "Titan" companies, such as Titan America (TTAM - cement) or Titan Pharmaceuticals (TTNP), which are entirely different businesses. Google's Finance Data
The "Titan" you see today is likely the "Resulting Issuer" known as Conavi Medical Corp (CNVI.V), which focuses on image-guided technologies for minimally invasive heart procedures rather than surgical robotics. 2. Listing Status and Liquidity
This is essentially a penny stock subject to extreme price swings. Industry Interest
